AI Encompassing: From Soaring Caseloads to Broadened Biopharma Territory - Qinecsa

AI Encompassing: From Soaring Caseloads to Broadened Biopharma Territory

Qinecsa CEO, Adam Sherlock, has been featured in Pharma Times’ latest issue, where he discusses how embracing next-generation, AI-driven process automation supports pharma with ongoing drug safety monitoring. He highlights, however, that AI should never replace human expertise – together efficiency improves sharply, with exposure and training helping to continuously refine accuracy.

Read article

Recent Articles

The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?

Embracing quantitative signal detection methods as a smaller MAH

Real-Time Safety Signals Drive Continuous PV Insight

From Complaint Handling to Active Surveillance

Continuous Safety Surveillance for Medical Devices

Are patient outcomes getting lost in safety data complexity?

PreviousHuman and Machine: A New Standard in Pharmacovigilance

NextA Critical Inflection Point: The Indisputable Case for Next-Gen Pharmacovigilance